ArticleJPEN. Journal of parenteral and enteral nutrition2025
Body composition in patients with obesity-related heart failure with preserved ejection fraction: A comparison study.
Article in JPEN. Journal of parenteral and enteral nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Glucagon-like Peptide-1 Therapy in Obesity-Related Heart Failure with Preserved Ejection Fraction: Mechanisms, Clinical Evidence, and Implications.Journal of clinical medicine · 2026Review
- Body composition in patients with obesity-related heart failure with preserved ejection fraction: A comparison study.JPEN. Journal of parenteral and enteral nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAppendicular lean mass index is a major determinant of cardiorespiratory fitness in patients with obesity-related heart failure with preserved ejection fraction (HFpEF). Moreover, appendicular lean mass index can be used to diagnose sarcopenia and sarcopenic obesity in this population. We aimed to validate the ability of segmental single-frequency bioelectrical impedance analysis (SF-BIA) to assess body composition compared with dual-energy x-ray absorptiometry (DXA) in patients with HFpEF and obesity, with a focus on appendicular lean mass index for its critical role in diagnosing sarcopenia and sarcopenic obesity.
methodsWe analyzed 62 euvolemic patients from a heart failure outpatient clinic with persistent obesity-related HFpEF (83.8% women, 60.8 ± 2.8 years of age). We used DXA and segmental SF-BIA.
resultsStrong correlations were found between segmental SF-BIA and DXA for appendicular lean mass index (r = 0.897), appendicular fat mass index (r = 0.864), fat mass (r = 0.968), fat mass percentage (r = 0.867), fat-free mass (r = 0.954), fat-free mass percentage (r = 0.852), fat mass index (r = 0.97), and fat-free mass index (r = 0.88) (all p < 0.001), without significant proportional bias for all parameters, except for appendicular fat mass index.
conclusionsSegmental SF-BIA-measured body composition shows strong correlations, appropriate agreements, and no proportional bias compared with DXA. Segmental SF-BIA should be considered in patients with obesity-related HFpEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.